Compugen Ltd
Clinical trials sponsored by Compugen Ltd, explained in plain language.
-
New hope for ovarian cancer: can COM701 delay relapse?
Disease control Recruiting nowThis study tests an experimental drug called COM701 in people with ovarian cancer that came back after treatment but still responds to platinum chemotherapy. The goal is to see if COM701, given as a maintenance therapy every three weeks, can delay cancer progression longer than a…
Phase: PHASE1, PHASE2 • Sponsor: Compugen Ltd • Aim: Disease control
Last updated May 17, 2026 05:30 UTC
-
New hope for advanced cancer: first human trial of COM503 begins
Disease control Recruiting nowThis early-stage trial tests a new drug called COM503, alone or with another drug (zimberelimab), in about 200 people with advanced solid tumors that have not responded to standard treatments. The main goal is to check safety and find the best dose. It is a first step to see if t…
Phase: PHASE1 • Sponsor: Compugen Ltd • Aim: Disease control
Last updated May 14, 2026 12:05 UTC